Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Open-Label Extension of Other SZ1839 (Iressa) Trials

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: March 7, 2008
Last updated: April 21, 2009
Last verified: April 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2003
  Estimated Primary Completion Date: No date given